drugset / Trial / NCT01062529

Peripheral Metabolic Effects of Somatostatin

NCT01062529

RandomizedSingle-groupSingle-blindBasic science

Summary

The aim of this study is to investigate peripheral effects of Somatostatin on glucose metabolism and growth hormone (GH) signalling in healthy men. Eight subjects will be enrolled. The hypothesis is that Somatostatin infusion reverses insulin resistance caused by GH.

Timeline

Start
2009-10
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatostatin Traditional medicine (herbal / TCM) 150 ug Other